Omnimmune Holdings (merged with Roughneck) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Omnimmune Holdings (merged with Roughneck) General Information

Description

Developer of cancer therapeutic medicines. The company provides diagnostic and prognostic technologies for cancer treatment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • 4550 Post Oak Place Drive
  • Suite 224
  • Houston, TX 77027
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnimmune Holdings (merged with Roughneck) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Omnimmune Holdings (merged with Roughneck)‘s full profile, request access.

Request a free trial

Omnimmune Holdings (merged with Roughneck) Executive Team (2)

Name Title Board Seat Contact Info
Harris Lichtenstein Chief Executive Officer, President, Director & Founder
You’re viewing 1 of 2 executive team members. Get the full list »